$RKDA
Arcadia Biosciences, Inc.

2017 Q1 Form 10-Q Financial Statement

#000156459017010318 Filed on May 10, 2017

View on sec.gov

Income Statement

Concept 2017 Q1 2016 Q1
Revenue $1.018M $852.0K
YoY Change 19.48% 4.54%
Cost Of Revenue $106.0K $147.0K
YoY Change -27.89% 162.5%
Gross Profit $912.0K $705.0K
YoY Change 29.36% -7.11%
Gross Profit Margin 89.59% 82.75%
Selling, General & Admin $3.052M $3.436M
YoY Change -11.18% 30.25%
% of Gross Profit 334.65% 487.38%
Research & Development $1.823M $2.202M
YoY Change -17.21% 20.2%
% of Gross Profit 199.89% 312.34%
Depreciation & Amortization $80.00K $70.00K
YoY Change 14.29% 0.0%
% of Gross Profit 8.77% 9.93%
Operating Expenses $4.981M $5.785M
YoY Change -13.9% 27.82%
Operating Profit -$3.963M -$4.933M
YoY Change -19.66% 32.93%
Interest Expense $339.0K $327.0K
YoY Change 3.67% -29.98%
% of Operating Profit
Other Income/Expense, Net $96.00K $76.00K
YoY Change 26.32% -105.44%
Pretax Income -$4.206M -$5.184M
YoY Change -18.87% -7.0%
Income Tax $10.00K $10.00K
% Of Pretax Income
Net Earnings -$4.216M -$5.190M
YoY Change -18.77% -10.56%
Net Earnings / Revenue -414.15% -609.15%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.901M -$2.348M
COMMON SHARES
Basic Shares Outstanding 44.51M 44.22M
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q1 2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $48.53M $50.19M
YoY Change -3.31% 344.95%
Cash & Equivalents $7.559M $29.54M
Short-Term Investments $40.97M $20.65M
Other Short-Term Assets $1.280M $1.330M
YoY Change -3.76% 432.0%
Inventory $240.0K $320.0K
Prepaid Expenses
Receivables $400.0K $690.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $50.44M $52.54M
YoY Change -4.0% 324.63%
LONG-TERM ASSETS
Property, Plant & Equipment $490.0K $660.0K
YoY Change -25.76% -0.45%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $14.91M
YoY Change -100.0% 2882.0%
Other Assets $1.720M $2.010M
YoY Change -14.43% -46.87%
Total Long-Term Assets $2.210M $17.57M
YoY Change -87.42% 149.33%
TOTAL ASSETS
Total Short-Term Assets $50.44M $52.54M
Total Long-Term Assets $2.210M $17.57M
Total Assets $52.65M $70.11M
YoY Change -24.9% 261.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $20.00K $10.00K
YoY Change 100.0% -87.5%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $2.083M
YoY Change
Total Short-Term Liabilities $5.170M $4.160M
YoY Change 24.28% -65.49%
LONG-TERM LIABILITIES
Long-Term Debt $23.09M $24.98M
YoY Change -7.55% 190.85%
Other Long-Term Liabilities $6.010M $5.490M
YoY Change 9.47% 83.0%
Total Long-Term Liabilities $23.09M $24.98M
YoY Change -7.55% -6.52%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.170M $4.160M
Total Long-Term Liabilities $23.09M $24.98M
Total Liabilities $34.28M $34.63M
YoY Change -1.01% -10.69%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $18.37M $35.48M
YoY Change
Total Liabilities & Shareholders Equity $52.65M $70.11M
YoY Change -24.9% 261.02%

Cashflow Statement

Concept 2017 Q1 2016 Q1
OPERATING ACTIVITIES
Net Income -$4.216M -$5.190M
YoY Change -18.77% -10.56%
Depreciation, Depletion And Amortization $80.00K $70.00K
YoY Change 14.29% 0.0%
Cash From Operating Activities -$4.530M -$4.860M
YoY Change -6.79% 86.92%
INVESTING ACTIVITIES
Capital Expenditures $57.00K $137.0K
YoY Change -58.39% 1857.14%
Acquisitions
YoY Change
Other Investing Activities $10.12M $10.47M
YoY Change -3.34%
Cash From Investing Activities $10.06M $10.33M
YoY Change -2.61% -103400.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 20.00K 90.00K
YoY Change -77.78% -103.35%
NET CHANGE
Cash From Operating Activities -4.530M -4.860M
Cash From Investing Activities 10.06M 10.33M
Cash From Financing Activities 20.00K 90.00K
Net Change In Cash 5.550M 5.560M
YoY Change -0.18% -204.91%
FREE CASH FLOW
Cash From Operating Activities -$4.530M -$4.860M
Capital Expenditures $57.00K $137.0K
Free Cash Flow -$4.587M -$4.997M
YoY Change -8.2% 91.68%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
23092000
CY2017Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
2083000
CY2016Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
25127000
CY2017Q1 us-gaap Contracts Revenue
ContractsRevenue
707000
CY2016Q1 us-gaap Contracts Revenue
ContractsRevenue
445000
CY2017Q1 us-gaap Sales Revenue Net
SalesRevenueNet
1018000
CY2016Q1 us-gaap Sales Revenue Net
SalesRevenueNet
852000
CY2017Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
106000
CY2016Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
147000
CY2017Q1 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
36000
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-4216000
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
CY2016Q1 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-76000
CY2017Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
44360189
CY2017Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1000
CY2017Q1 us-gaap Share Based Compensation
ShareBasedCompensation
371000
CY2017Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-62000
CY2016Q1 us-gaap Share Based Compensation
ShareBasedCompensation
221000
CY2017Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
49000
CY2016Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2202000
CY2017Q1 us-gaap Interest Expense
InterestExpense
339000
CY2016Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
84000
CY2016Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5106000
CY2017Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
81000
CY2016Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
67000
CY2017Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
3000
CY2016Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
48000
CY2017Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-65000
CY2016Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-119000
CY2017Q1 us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
-72000
CY2016Q1 us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
24000
CY2016Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-14000
CY2017Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
404000
CY2016Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
641000
CY2017Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
423000
CY2017Q1 us-gaap Licenses Revenue
LicensesRevenue
106000
CY2016Q1 us-gaap Licenses Revenue
LicensesRevenue
152000
CY2016Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3436000
CY2016Q1 us-gaap Operating Expenses
OperatingExpenses
5785000
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4933000
CY2016Q1 us-gaap Interest Expense
InterestExpense
327000
CY2017Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
96000
CY2016Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
76000
CY2017Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4206000
CY2016Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5184000
CY2017Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10000
CY2016Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
152000
CY2017Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-176000
CY2016Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
414000
CY2017Q1 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-10000
CY2016Q1 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-7000
CY2017Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
38000
CY2016Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
200000
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-4530000
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-4855000
CY2017Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
4000
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
57000
CY2016Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
137000
CY2017Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
4582000
CY2017Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
14695000
CY2016Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
10465000
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
10060000
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
10328000
CY2016Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
45000
CY2017Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
16000
CY2016Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
139000
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
16000
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
94000
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
5546000
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
5567000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23973000
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29540000
CY2017Q1 us-gaap Interest Paid
InterestPaid
288000
CY2016Q1 us-gaap Interest Paid
InterestPaid
193000
CY2016Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
1000
CY2017Q1 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
2000
CY2017Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2000
CY2016Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1000
CY2017Q1 dei Entity Incorporation State Country Name
EntityIncorporationStateCountryName
Arizona
CY2017Q1 rkda Entity Incorporation Year Of Incorporation
EntityIncorporationYearOfIncorporation
2002
CY2017Q1 rkda Entity Reincorporation State Country Name
EntityReincorporationStateCountryName
Delaware
CY2017Q1 rkda Entity Reincorporation Date Of Reincorporation
EntityReincorporationDateOfReincorporation
2015-03
CY2017Q1 rkda Inventory Raw Materials Current And Non Current
InventoryRawMaterialsCurrentAndNonCurrent
44000
CY2016Q4 rkda Inventory Raw Materials Current And Non Current
InventoryRawMaterialsCurrentAndNonCurrent
44000
CY2017Q1 rkda Inventory Finished Goods Current And Non Current
InventoryFinishedGoodsCurrentAndNonCurrent
1474000
CY2016Q4 rkda Inventory Finished Goods Current And Non Current
InventoryFinishedGoodsCurrentAndNonCurrent
1535000
CY2017Q1 rkda Inventory Current And Non Current Net
InventoryCurrentAndNonCurrentNet
1518000
CY2016Q4 rkda Inventory Current And Non Current Net
InventoryCurrentAndNonCurrentNet
1579000
CY2017Q1 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
47849000
CY2017Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0
CY2017Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
20000
CY2017Q1 us-gaap Available For Sale Securities
AvailableForSaleSecurities
47829000
CY2016Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
52613000
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
19000
CY2016Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
52594000
CY2017Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0
CY2017Q1 rkda Maturity Of Short Term Investments
MaturityOfShortTermInvestments
2017
CY2017Q1 rkda Maturity Of Long Term Investments
MaturityOfLongTermInvestments
2018
CY2017Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
47829000
CY2016Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
52594000
CY2017Q1 us-gaap Variable Interest Entity Terms Of Arrangements
VariableInterestEntityTermsOfArrangements
Both the Company and Bioceres incur expenses in support of specific agreed activities, as defined by joint work plans, which apply fair market value to each partner’s activities. Unequal contributions of services are equalized by the partners through cash payments. Verdeca is not the primary obligor for these activities performed by the Company or Bioceres. An agreement executed in conjunction with the formation of Verdeca specified that if Bioceres determines it requires cash to fund its contributed services (subject to certain annual limits), Bioceres, S.A. may elect to sell shares of its common stock to the Company for an amount not exceeding $5.0 million in the aggregate over a four-year period.
CY2017Q1 rkda Contributed Services Period
ContributedServicesPeriod
P4Y
us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
2000000
CY2014Q3 rkda Common Stock Shares Surrendered
CommonStockSharesSurrendered
1832
CY2015 rkda Research Agreement Settled
ResearchAgreementSettled
205000
CY2015Q4 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
632
CY2015Q4 us-gaap Fair Value Hedges At Fair Value Net
FairValueHedgesAtFairValueNet
500000
CY2015Q4 us-gaap Cost Method Investments
CostMethodInvestments
0
CY2017Q1 us-gaap Variable Interest Entity Activity Between Vie And Entity Expense
VariableInterestEntityActivityBetweenVIEAndEntityExpense
92000
CY2016Q1 us-gaap Variable Interest Entity Activity Between Vie And Entity Expense
VariableInterestEntityActivityBetweenVIEAndEntityExpense
40000
CY2017Q1 us-gaap Notes Payable To Bank Noncurrent
NotesPayableToBankNoncurrent
25175000
CY2016Q4 us-gaap Notes Payable To Bank Noncurrent
NotesPayableToBankNoncurrent
25127000
CY2017Q1 us-gaap Long Term Debt
LongTermDebt
25175000
CY2016Q4 us-gaap Long Term Debt
LongTermDebt
25127000
CY2016Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0
CY2017Q1 rkda Number Of Equity Incentive Plans
NumberOfEquityIncentivePlans
2
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4578782
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
198483
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4380299
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
4346958
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2713195
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.38
CY2017Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.36
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.42
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
4.41
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.65
CY2017Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1600000
CY2017Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y10M13D
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2017Q1 rkda Class Of Warrant Or Right Exercisable Term
ClassOfWarrantOrRightExercisableTerm
P5Y
CY2017Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2017Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.002
CY2016Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.001
CY2017Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2017Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5717193
CY2016Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4708689

Files In Submission

Name View Source Status
0001564590-17-010318-index-headers.html Edgar Link pending
0001564590-17-010318-index.html Edgar Link pending
0001564590-17-010318.txt Edgar Link pending
0001564590-17-010318-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rkda-10q_20170331.htm Edgar Link pending
rkda-20170331.xml Edgar Link completed
rkda-20170331.xsd Edgar Link pending
rkda-20170331_cal.xml Edgar Link unprocessable
rkda-20170331_def.xml Edgar Link unprocessable
rkda-20170331_lab.xml Edgar Link unprocessable
rkda-20170331_pre.xml Edgar Link unprocessable
rkda-ex311_7.htm Edgar Link pending
rkda-ex312_10.htm Edgar Link pending
rkda-ex321_8.htm Edgar Link pending
rkda-ex322_6.htm Edgar Link pending
Show.js Edgar Link pending